Терафлекс

Терафлекс – means for treatment of degenerative diseases of a musculoskeletal system.

Pharmacological action of Terafleks

Two active components – chondroitin sulfate and a glycosamine are Terafleks's part. Both of them strengthen regeneration (recovery) of a cartilage of joint surfaces at degenerative defeats.

The glycosamine participates in formation of the glikozaminoglikan (including hyaluronic acid) making a basis of cartilaginous tissue. Performing functions of antioxidants, it protects cartilaginous tissue from destruction by oxygen radicals who are formed at an inflammation. Also the glycosamine protects a cartilage of joint surfaces from destructive influence of products of metabolism when using non-steroidal anti-inflammatory drugs and glucocorticoids. There are data on its moderate antiinflammatory influence.

Chondroitin sulfate on a structure concerns to group of mucopolysaccharides. It reduces activity of the enzymes destroying a cartilage. Stimulating formation of proteoglycans, collagen and a gialuronon, it also recovers structure of cartilaginous tissue and maintains necessary viscosity of joint liquid. The glycosamine and chondroitin sulfate in a complex potentsiirut action of each other.

Terafleks's use slows down a degeneration of joint cartilages and improves a metabolism in cartilaginous tissue. Thanks to it joint pains and constraint in them decrease at the movement. According to Terafleks allows to reduce a dosage of NPVS and anesthetics.

Drug is soaked up from a digestive tract and reaches the greatest concentration in blood serum in 4 hours, and in joint liquid in 4 – 5 hours. About a third of its concentration get to joint liquid and cartilaginous tissue. Low bioavailability is connected with the large size of molecules of a glycosamine and sulfate chondroitin.

Medicine in a liver with formation of safe products of exchange is metabolized, and within a day brought out of an organism by kidneys.

There are several analogs of Terafleks, additional components which strengthen medical effect are their part. For example, as a part of Terafleks Advans also NPVS an ibuprofen contains, and Terafleks of M in the form of ointment includes camphor and oil of mint.

Release form

According to the instruction of Terafleks release in capsules.

Indications to Terafleks's use

Drug is used in complex treatment of diseases of bone and joint system in the presence of degenerative changes of cartilaginous tissue. Treat them – osteoarthroses, osteoporosis, a spondylosis, osteochondrosis and other degenerative and dystrophic diseases of a backbone. Received good comments of Terafleks in practice of posttraumatic states – it accelerates formation of a bone callosity and, respectively, accretion of bones at changes.

Contraindications

According to the instruction of Terafleks it is contraindicated at intolerance of its components, at a fenilketonuriya, to children 15 years are younger. Reviews of Terafleksa during pregnancy and feeding by a breast are absent therefore administration of drug at these states is not recommended.

With care use at the raised bleeding is possible, a diabetes mellitus, a chronic renal failure.

Application instruction of Terafleks

Drug is accepted inside, washing down with water, irrespective of meal. In the first 3 weeks recommend on 1 capsule 3 times a day, further to continue reception on 1 capsule 2 times a day within 3 – 6 months. Course duration depending on a stage of a disease is determined by the doctor. After a break in 1 month the course is repeated if necessary.

It is important to remember that, as well as its analogs, Terafleks are strengthened by effect of anticoagulants. It also reduces activity of penicillinic antibiotics.

Side effects

Usually Terafleks's use is safe and does not break health of patients. Seldom there are abdominal pains, diarrhea, a lock, a headache, drowsiness, sleeplessness or allergic reactions.